Exploring the Role of Ponesimod in Managing Secondary Progressive Multiple Sclerosis
Ponesimod, known commercially as Ponvory, marks a pivotal advancement in managing secondary progressive multiple sclerosis (SPMS). By modulating immune responses, it reduces relapses and slows disability progression. This article delves into its administration, clinical efficacy, safety, and necessary precautions, offering a comprehensive understanding of its role in SPMS treatment. Understanding Ponesimod and Its Role in […]
3 minute read